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TO THE EDITOR:
In 2004, Pöyhönen et al. reported on three unrelated patientswith
hypertrichosis, hyperkeratosis, abnormal corpus callosum, intellectual
disability (ID), and minor anomalies including low anterior hairline,
thick arched eyebrows, broad nasal tip, columella below alae nasi,
short philtrum, thick-everted lower lip, simple posteriorly angulated
ears, and broad feet and finger tips (Pöyhönen et al., 2004). This
observation was recognized as an OMIM entity (OMIM 609943),
hereafter referred to as HHID syndrome. In 2009, Dalal and Mehrotra
(2009) reported a further patient with HHID syndrome who
additionally presented with short stature, short 4th and 5th toes,
mild dilatation of the supratentorial ventricular system and
nephrolithiasis. No further individual with suspected HHID has been
published and the cause of their condition remained elusive. We now
used whole exome sequencing (WES) in the three patients published
by Pöyhönen et al. (2004) and discuss the updated phenotype in the
light of today’s clinical knowledge and our genetic findings.
The detailed initial clinical description of patient 1 (P1, at age of 16
years), patient 2 (P2, at age of 17 years), and patient 3 (P3, at age of 10
years), all born to non-consanguineous parents from different parts of
Finland, is provided in the original article by Pöyhönen et al. (2004).
Clinical reassessmentof the threepatients after about10years revealed
the previously described phenotype, except for hypertrichosis, which
now resembled normal variation. Additionally, behavior anomalies such
as severe obsessive-compulsive and autistic behavior and a hoarse or
high pitched voice were noted (Table 1, Figure 1).
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Results of conventional karyotyping, subtelomeric FISH studies
and targeted testing of CREBBP were normal. We then performed
high resolution chromosomal microarray testing which did not reveal
any apparent pathologic variant followed by WES in P1 and trio-
WES in P2 and P3 and their healthy parents. The study was
approved by the ethical committee of the canton of Zurich. Filtering
for rare, non-synonymous exonic, and splice site variants in 821
known and 424 candidate ID genes (based on the SysID database,
[Kochinke et al., 2016]), considering both dominant and recessive
modes of inheritance, revealed pathogenic de novo loss of function
mutations in ARID1B in P2 and P3. In P2, we identified a
heterozygous deletion of 4 bp (NM_020732.3:c.5570_5573del) in
the last coding exon of ARID1B, which causes a frameshift resulting
in a premature truncation after 16 amino acids and thereafter a
TABLE 1 Updated clinical features of HHID patients
Patients P1 P2 P3
Genetic defect Unknown ARID1B: c.5570_5573del
(p.Lys1857Serfs*17)
ARID1B: c.4110G>A
(p.His1339Ilefs*77)
Age at
investigation
25 y 26 y 19 y
Growth
parameters
Height 156.3 cm (−1.6 SD) 155 cm (−1.8 SD) 154.5 cm (−1.8 SD)
OFC 55 cm (0 SD) 56.5 cm (+1 SD) 54.5 cm (−0.5 SD)
BMI 19.3 32 25.1
Menarche 9 y 13 y 15 y
Health
Malformations Thick and short corpus callosum VSD, PDA, mild CoA. Cong. hip dislocation,
midline supraumbilical hernia, cong. ptosis of
right eye, no cerebral MRI
Thick and short corpus callosum
Vision Strabism, myopia right, hyperopia left Strabism, myopia Myopia
General Recurrent ear infections—tube
insertion & adenotomy (5 y) enuresis
up to 10 y
Recurrent ear infections—tube insertion &
adenotomy (7 y) hemicrania
Severe atopic eczema
Ectodermal signs
Hypertrichosis Vanished Vanished Vanished
Hyperkeratotic
skin plaques
Neck, shoulders, axillary area, between
the breasts, and on the lower
abdominal and dorsal areas
Middle of the back Lower and upper limbs
Nails Mild hypoplasia Mild hypoplasia Mild hypoplasia
Behaviour &
development
Walking 1 y 8mo 2 y 4mo 1 y 6mo
Speech
development
(sentences)
2 y 4 y 5 y
Academic
achievements
Reads, writes, counts Reads, writes, counts Reads, writes, counts
ID Mild Mild-moderate Mild
Voice & speech
behaviour
Voice hoarse, increasing inertia to
speak
Voice hoarse, feeble; speech slurred, finally
total refusal to speak
Voice high pitched; slurred
speech, rapid change of pitch,
diminishing use of speech
Sleeping
problems
reverse sleeping rhythm No No
Behaviour/
personality
Withdrawn, stubborn, irritated,
passive, temper tantrums, detests
presence of others
Withdrawn, obstinate, passive, obsessive-
compulsive, detests presence of others
Withdrawn, autistic, obsessive
compulsive, detests presence
of others
Cognitive
regression
No (severe visuospatial and motor
problems)
No No
y, years; mo, month; OFC, occipito-frontal circumference; BMI, body mass index; SD, standard deviation score; MRI, magnetic resonance imaging; VSD,
ventricular septal defect; PDA, patent ductus arteriosus; CoA., coaxial; Cong., congenital; ID, intellectual disability.
ZWEIER ET AL. | 1441
significantly truncated protein (p.Lys1857Serfs*17). This mutation
has not been reported before and de novo occurrence was
confirmed by Sanger sequencing in the patient and her parents.
WES in P3 and her parents revealed a heterozygous de novo
mutation of the last coding basepair of exon 17 (NM_020732.3:
c.4110G>A), which was predicted to be synonymous, but located in
the conserved consensus splice donor site. This mutation had been
reported previously in a patient with nonspecific ID and results in
skipping of exon 17 in RNA from patient lymphocytes (Hoyer et al.,
2012). Therefore, it was predicted to cause a frameshift resulting in a
premature translational termination (p.His1339Ilefs*77); and thus,
possibly in nonsense-mediated mRNA-decay. In P1, no obvious
pathogenic or likely pathogenic loss of function mutation in a known
ID gene could be detected, although the whole coding region of
ARID1B was covered at least 20-fold and MLPA analysis showed
normal dosage for all exons. Of note, additional mutation screening
of all variants in related ID genes (ARID1B, SMARCA4, SMARCB1,
SMARCE1, SMARCA2, TBC1D24, SOX11, PHF6, TBC1D24, ADNP, and
KMT2A) revealed no obvious pathogenic variant, either. However,
interpretation of missense variants in other genes and analysis of
novel candidate genes were hampered by the fact that the father
was not available and a trio approach therefore not feasible.
Our findings establish mutations in ARID1B as the underlying
genetic defect in the HHID syndrome in two of three patients.
The underlying genetic defect in P1 remains currently elusive,
however, an undetected non-coding mutation of ARID1B cannot be
excluded.
Haploinsufficiency of ARID1B was recently implicated in both,
nonsyndromic ID and Coffin-Siris Syndrome (CSS, OMIM #135900)
(Hoyer et al., 2012; Santen et al., 2012; Tsurusaki et al., 2012). There is
accumulating evidence that ARID1B is one of the most commonly
mutated genes in ID and is associated with a broad phenotypic range
(Deciphering Developmental Disorders, 2015; Hoyer et al., 2012;
Santen & Clayton-Smith, 2014). The core phenotype of ARID1B
mutated patients, present in almost all patients with a prior CSS
diagnosis, comprises ID (100%), speech delay (100%), “coarse facies”
(95%), and hypertrichosis (95%). Common further anomalies were
small 5th finger or toe nails (81%), short fifth finger (73%), feeding
difficulties (65%), agenesis of the corpus callosum (35%), seizures
(23%), myopia (20%), and growth delay (19% height <−2.5 SDS, 71%
height <0 SDS) (Santen & Clayton-Smith, 2014). Retrospectively, the
HHID patients’ phenotypes fit well into the published ARID1B-
associated clinical spectrum including the key features of ID,
hypertrichosis, abnormal corpus callosum, and coarse face. However,
our patients show only mildly diminished nail size and demonstrate
that the key feature of hypertrichosis vanishes to levels of normal
variation during adolescence. Moreover, the most distinctive feature
shared by all patients with suspected HHID (Dalal & Mehrotra, 2009;
Pöyhönen et al., 2004) is the ectodermal sign of hyperkeratotic
plaques which has not yet been reported in any patient with CSS or
ARID1B-associated nonspecific ID. This might therefore constitute
either an underreported or an infrequent but distinct novel feature of
ARID1B-associated phenotypes. However, reevaluation of patients
with ARID1B mutations is needed to assess the true incidence of
FIGURE 1 Phenotypes of patients with suspected HHID syndrome at clinical reinvestigation after about 10 years. Facial gestalt, hand and
foot, and a location with hyperkeratotic plaques is shown for P1 at the age of 25 years (A-E), for P2 at the age of 26 years (F-J), and for P3 at
the age of 19 years (K-N). Of note, the picture with hyperkeratotic plaques for P3 (O) was taken at the age of 16 years
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hyperkeratotic plaques, which may become only obvious with
increasing age.
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